Dow Down0.03% Nasdaq Up0.50%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
2.25 Up 0.03(1.35%) 3:36PM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 854   1,989   1,995   1,989  
Cost of Revenue -   -   -   -  
Gross Profit 854   1,989   1,995   1,989  
Operating Expenses
Research Development6,939  7,206  7,552  6,883  
Selling General and Administrative7,226  6,387  3,417  2,698  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,311) (11,604) (8,974) (7,592)
Income from Continuing Operations
Total Other Income/Expenses Net(1,623)293  (5,052)1,038  
Earnings Before Interest And Taxes(14,934)(11,311)(14,026)(6,554)
Interest Expense391  470  547  623  
Income Before Tax(15,325)(11,781)(14,573)(7,177)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(15,325)(11,781)(14,573)(7,177)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (15,325) (11,781) (14,573) (7,177)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (15,325) (11,781) (14,573) (7,177)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.